Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN96,0396,213,90
Msft0,24
Nokia5,5025,6480,43
IBM0,50
Mercedes-Benz Group AG60,4560,470,68
PFE0,75
10.01.2026 0:38:51
Indexy online
AD Index online
select
AD Index online
 

  • 09.01.2026
Safran (SAF.F, Frankfurt)
Závěr k 9.1.2026 Změna (%) Změna (EUR) Objem obchodů (EUR)
318,60 -0,99 -3,20 20 338
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti

Business Summary: Safran SA is a France-based high-technology company that carries out research, design, development, testing, manufacturing, sales, maintenance, and support operations for its high-technology activities. The Company’s segments are: Aerospace Propulsion, Aircraft Equipment and Aircraft Interiors. The Aerospace Propulsion segment designs, develops, produces, and markets, propulsion and mechanical power transmission systems for commercial aircraft, military transport, training and combat aircraft, civil and military helicopters, satellites, and drones. It also includes maintenance, repair, and overhaul (MRO) activities and the sale of spare parts. The Aircraft Equipment segment operates in five main sectors: Landing and braking systems, Engine systems and equipment, Electrical systems, and engineering, Aerosystems, and Electronics & Defense. The Aircraft Interiors segment covers seats and cabin fittings, closets, in-flight entertainment systems and flight-deck equipment.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Safran SA revenues increased 13% to EUR14.87B. Net income increased from EUR57M to EUR5.05B. Revenues reflect Propulsion segment increase of 17% to EUR7.54B, Equipment & Defense segment increase of 8% to EUR5.61B, Aircraft Interiors segment increase of 15% to EUR1.62B. Net income benefited from Propulsion segment income increase of 37% to EUR1.76B.



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Supervisory BoardStephan Goeckeler-02.01.201302.01.2013
Deputy Chairman of the Supervisory BoardDirk Ruettgers-01.01.2017
Member of the Management BoardGeorg Issels-01.01.2013
Member of the Management BoardHans Neuroth-01.01.201301.01.2013